RACGAP1 and breast carcinoma: As with our RACGAP1 finding, we determined significantly higher differential mRNA expression of EF2F1 in LumB versus LumA breast cancers via edgeR analysis (FDR = 2.59 × 10−27; logFC = −1.34).